Industry News
Biotechnology Industry News

‘What it takes’: Beyond the headlines, women are pushing groundbreaking new Alzheimer’s treatments forward
'What it takes': Beyond the headlines, women are pushing groundbreaking new Alzheimer's treatments forward aarmstrong Fri, 11/19/2021 - 11:53
New insights into how cancer cripples immune cells could fuel fresh I-O approaches
New insights into how cancer cripples immune cells could fuel fresh I-O approaches arlene.weintraub Fri, 11/19/2021 - 09:30
Enanta dumps oral hep B program after safety warnings in early test
Enanta dumps oral hep B program after safety warnings in early test badams Fri, 11/19/2021 - 08:13
Fresh from $2.5B pact, BridgeBio, Helsinn expand collaboration to cover preclinical cancer prospects
Fresh from $2.5B pact, BridgeBio, Helsinn expand collaboration to cover preclinical cancer prospects ntaylor Fri, 11/19/2021 - 07:28
Merck pauses ‘very important’ HIV program after seeing red flag in phase 2 trial of once-weekly combo
Merck pauses 'very important' HIV program after seeing red flag in phase 2 trial of once-weekly combo ntaylor Fri, 11/19/2021 - 05:04
Personalized T cells could offer an immunotherapy option to children with brain tumors
Personalized T cells could offer an immunotherapy option to children with brain tumors arlene.weintraub Thu, 11/18/2021 - 13:54
Data manipulation expert Elisabeth Bik compares the tales of 2 accused biotechs: Cassava and Athira
Data manipulation expert Elisabeth Bik compares the tales of 2 accused biotechs: Cassava and Athira aarmstrong Thu, 11/18/2021 - 13:50
J&J previews $60B-a-year future with plans to go after viruses that have long evaded vaccine makers
J&J previews $60B-a-year future with plans to go after viruses that have long evaded vaccine makers aarmstrong Thu, 11/18/2021 - 12:26
Novo Nordisk bets big on RNAi, paying $3.3B to buy Dicerna
Novo Nordisk bets big on RNAi, paying $3.3B to buy Dicerna ntaylor Thu, 11/18/2021 - 08:24
Gilead hits go on a host of Arcus cancer programs but forgoes rumored buyout in a $725M pact as TIGIT leads the way
Gilead hits go on a host of Arcus cancer programs but forgoes rumored buyout in a $725M pact as TIGIT leads the way badams Thu, 11/18/2021 - 07:50
With FDA scrutinizing its data, AstraZeneca shows durability of COVID-preventing antibodies
With FDA scrutinizing its data, AstraZeneca shows durability of COVID-preventing antibodies ntaylor Thu, 11/18/2021 - 06:31
Psychedelic psilocybin cuts cravings and boosts key brain functions in rat models of alcohol use disorder
Psychedelic psilocybin cuts cravings and boosts key brain functions in rat models of alcohol use disorder klahucik Wed, 11/17/2021 - 15:53
Valo whacks SPAC merger, blaming ‘market conditions’ for end of $750M Khosla deal
Valo whacks SPAC merger, blaming 'market conditions' for end of $750M Khosla deal ntaylor Wed, 11/17/2021 - 08:53
Eloxx ends long wait for phase 2 cystic fibrosis data. Market shrugs
Eloxx ends long wait for phase 2 cystic fibrosis data. Market shrugs ntaylor Wed, 11/17/2021 - 08:09
Fine-tuning targeted therapy for multiple myeloma with ‘multi-omics’ data
Fine-tuning targeted therapy for multiple myeloma with 'multi-omics' data aliu Wed, 11/17/2021 - 06:48
As Merck and Pfizer predict incoming billions from their COVID drugs, Roche culls pandemic ties with Atea
As Merck and Pfizer predict incoming billions from their COVID drugs, Roche culls pandemic ties with Atea badams Wed, 11/17/2021 - 04:44
Novartis-partnered DARPin flames out in COVID-19 study, sending Molecular Partners’ stock into nosedive
Novartis-partnered DARPin flames out in COVID-19 study, sending Molecular Partners' stock into nosedive ntaylor Tue, 11/16/2021 - 08:03
UPDATE: Sandrock makes a sharp exit, retiring as Biogen R&D chief amid fallout from Aduhelm approval
UPDATE: Sandrock makes a sharp exit, retiring as Biogen R&D chief amid fallout from Aduhelm approval ntaylor Tue, 11/16/2021 - 05:17
Medidata co-founder Glen de Vries dies in plane crash less than a month after Blue Origin flight
Medidata co-founder Glen de Vries dies in plane crash less than a month after Blue Origin flight aarmstrong Mon, 11/15/2021 - 11:07
Injectable ‘dancing molecules’ repair spinal cord injury, restore mobility in paralyzed mice
Injectable 'dancing molecules' repair spinal cord injury, restore mobility in paralyzed mice arlene.weintraub Mon, 11/15/2021 - 09:12

